首页> 美国卫生研究院文献>Genetics and Molecular Biology >Exome sequencing identifies a novel mutation of the GDI1gene in a Chinese non-syndromic X-linked intellectual disabilityfamily
【2h】

Exome sequencing identifies a novel mutation of the GDI1gene in a Chinese non-syndromic X-linked intellectual disabilityfamily

机译:外显子组测序鉴定出GDI1的新型突变中国非综合征X连锁智力障碍中的基因家庭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

X-linked intellectual disability (XLID) has been associated with various genes. Diagnosis of XLID, especially for non-syndromic ones (NS-XLID), is often hampered by the heterogeneity of this disease. Here we report the case of a Chinese family in which three males suffer from intellectual disability (ID). The three patients shared the same phenotype: no typical clinical manifestation other than IQ score ≤ 70. For a genetic diagnosis for this family we carried out whole exome sequencing on the proband, and validated 16 variants of interest in the genomic DNA of all the family members. A missense mutation (c.710G > T), which mapped to exon 6 of the Rab GDP-Dissociation Inhibitor 1 (GDI1) gene, was found segregating with the ID phenotype, and this mutation changes the 237th position in the guanosine diphosphate dissociation inhibitor (GDI) protein from glycine to valine (p. Gly237Val). Through molecular dynamics simulations we found that this substitution results in a conformational change of GDI, possibly affecting the Rab-binding capacity of this protein. In conclusion, our study identified a novel GDI1 mutation that is possibly NS-XLID causative, and showed that whole exome sequencing provides advantages for detecting novel ID-associated variants and can greatly facilitate the genetic diagnosis of the disease.
机译:X连锁智力障碍(XLID)与各种基因有关。 XLID的诊断(尤其是非综合症(NS-XLID)的诊断)通常因该疾病的异质性而受阻。在这里,我们报告了一个中国家庭的案例,其中三名男性患有智力残疾(ID)。这三名患者具有相同的表型:除IQ得分≤70外,没有其他典型的临床表现。对于该家族的遗传诊断,我们对先证者进行了完整的外显子组测序,并验证了全家族基因组DNA中感兴趣的16个变异体成员。发现一个错义突变(c.710G> T),它定位于Rab GDP-Dissociation Inhibitor 1(GDI1)基因的第6外显子,与ID表型分离,并且该突变改变了鸟苷二磷酸解离抑制剂的第237位。 (GDI)蛋白从甘氨酸到缬氨酸(p。Gly237Val)。通过分子动力学模拟,我们发现这种取代导致GDI的构象变化,可能影响该蛋白的Rab结合能力。总之,我们的研究确定了可能是NS-XLID病因的新型GDI1突变,并表明整个外显子组测序为检测与ID相关的新型变异提供了优势,并且可以极大地促进该疾病的遗传诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号